Krystal Biotech Stock
Price
Target price
€154.00
€154.00
-0.310%
-0.5
-0.310%
€166.84
18.04.24 / Tradegate
WKN: A2JH2F / Symbol: KRYS / Name: Krystal Biotech / Stock / Biotechnology & Medical Research / Small Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
Krystal Biotech Stock
Krystal Biotech shows a slight decrease today, losing -€0.500 (-0.310%) compared to yesterday.
Krystal Biotech is currently one of the favorites of our community with 15 Buy predictions and no Sell predictions.
With a target price of 166 € there is a slightly positive potential of 7.79% for Krystal Biotech compared to the current price of 154.0 €.
So far the community has only identified positive things for Krystal Biotech stock. The most positive votes were given for criterium "Worthwhile Investment for the next years".
Pros and Cons of Krystal Biotech in the next few years
Pros
?
M***** P*******
?
S********** s********
?
C******** o* t** e**********
Cons
?
B****
?
G***** c******* t* c**********
?
W********* I********* f** t** n*** y****
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Krystal Biotech vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Krystal Biotech | -0.310% | -5.897% | -0.645% | 88.957% | 32.759% | - | - |
| Ardelyx Inc. | 0.530% | -12.086% | -15.475% | 35.391% | 4.706% | -16.524% | - |
| Salarius Pharmaceuticals Inc. | 1.850% | 10.553% | -19.266% | -71.613% | -20.721% | -98.176% | -99.994% |
| Evolus Inc | -1.830% | -7.627% | -15.504% | 39.744% | 16.578% | 15.344% | - |
Comments
Krystal Biotech, Inc. (NASDAQ: KRYS) had its "buy" rating re-affirmed by analysts at Stifel Nicolaus. They now have a $204.00 price target on the stock, up previously from $178.00.
Show more
Ratings data for KRYS provided by MarketBeat
Krystal Biotech, Inc. (NASDAQ: KRYS) had its price target raised by analysts at Citigroup Inc. from $160.00 to $195.00. They now have a "buy" rating on the stock.
Show more
Ratings data for KRYS provided by MarketBeat
Krystal Biotech, Inc. (NASDAQ: KRYS) had its price target raised by analysts at Guggenheim from $130.00 to $175.00. They now have a "buy" rating on the stock.
Show more
Ratings data for KRYS provided by MarketBeat